| RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response A Penn-Nicholson, SK Mbandi, E Thompson, SC Mendelsohn, S Suliman, ... Scientific Reports 10 (1), 1-21, 2020 | 113 | 2020 |
| Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ... The Lancet Infectious Diseases 21 (3), 354-365, 2021 | 108 | 2021 |
| Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans P Rijal, SC Elias, SR Machado, J Xiao, L Schimanski, V O’Dowd, T Baker, ... Cell reports 27 (1), 172-186. e7, 2019 | 72 | 2019 |
| Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis H Mulenga, CZ Zauchenberger, EW Bunyasi, SK Mbandi, ... PloS one 15 (8), e0237574, 2020 | 46 | 2020 |
| Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study SC Mendelsohn, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, ... The Lancet Global Health 9 (6), e841-e853, 2021 | 43 | 2021 |
| Peripheral blood mucosal-associated invariant T (MAIT) cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls S Suliman, A Gela, SC Mendelsohn, SK Iwany, KL Tamara, S Mabwe, ... The Journal of Infectious Diseases, 2020 | 28 | 2020 |
| Longitudinal Dynamics of a Blood Transcriptomic Signature of Tuberculosis H Mulenga, M Musvosvi, SC Mendelsohn, A Penn-Nicholson, ... American Journal of Respiratory and Critical Care Medicine 204 (12), 1463-1472, 2021 | 21 | 2021 |
| Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR SC Mendelsohn, SK Mbandi, A Fiore-Gartland, A Penn-Nicholson, ... Communications medicine 2 (1), 26, 2022 | 17 | 2022 |
| Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20–22 April 2021 S Suliman, PT Pelzer, M Shaku, V Rozot, SC Mendelsohn Vaccine 39 (50), 7223-7229, 2021 | 15 | 2021 |
| Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools EW Bunyasi, K Middelkoop, A Koch, Z Hoosen, H Mulenga, AKK Luabeya, ... American journal of respiratory and critical care medicine 205 (3), 350-356, 2022 | 12 | 2022 |
| The Students' Health and Welfare Centres Organisation (SHAWCO) of the University of Cape Town: a review of the past 69 years: forum-history DM Favara, SC Mendelsohn South African Medical Journal 102 (6), 400-402, 2012 | 11 | 2012 |
| Clinical predictors of pulmonary tuberculosis among South African adults with HIV SC Mendelsohn, A Fiore-Gartland, D Awany, H Mulenga, SK Mbandi, ... eClinicalMedicine 45, 101328, 2022 | 8 | 2022 |
| Blood transcriptional signatures for tuberculosis testing SC Mendelsohn, SK Mbandi, M Hatherill, TJ Scriba The Lancet Respiratory Medicine 8 (4), 330-331, 2020 | 7 | 2020 |
| IL27 gene expression distinguishes multisystem inflammatory syndrome in children from febrile illness in a South African cohort TF Spracklen, SC Mendelsohn, C Butters, H Facey-Thomas, R Stander, ... Frontiers in immunology 13, 992022, 2022 | 6 | 2022 |
| Regional changes in tuberculosis disease burden among adolescents in South Africa (2005–2015) EW Bunyasi, H Mulenga, AKK Luabeya, J Shenje, SC Mendelsohn, ... PLOS ONE 15 (7), e0235206, 2020 | 6 | 2020 |
| Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic … H Mulenga, EW Bunyasi, SK Mbandi, SC Mendelsohn, B Kagina, ... BMJ open 9 (5), e026612, 2019 | 6 | 2019 |
| The impact of blood transcriptomic biomarker targeted tuberculosis preventive therapy in people living with HIV: a mathematical modelling study T Sumner, SC Mendelsohn, TJ Scriba, M Hatherill, RG White BMC medicine 19 (1), 1-11, 2021 | 5 | 2021 |
| Host blood transcriptomic biomarkers of tuberculosis disease in people living with HIV: a systematic review protocol SC Mendelsohn, H Mulenga, SK Mbandi, F Darboe, M Shelton, TJ Scriba, ... BMJ open 11 (8), e048623, 2021 | 5 | 2021 |
| Headway made towards biosignatures for incipient tuberculosis TJ Scriba, SC Mendelsohn The Lancet Respiratory Medicine 8 (4), 328-330, 2020 | 5 | 2020 |
| Evaluation of a transcriptomic signature of tuberculosis risk in combination with an interferon gamma release assay: A diagnostic test accuracy study H Mulenga, A Fiore-Gartland, SC Mendelsohn, A Penn-Nicholson, ... eClinicalMedicine 47, 101396, 2022 | 4 | 2022 |
Thomas ScribaProfessor, University of Cape TownVerified email at uct.ac.za
